News Focus
News Focus
Followers 23
Posts 3855
Boards Moderated 0
Alias Born 04/17/2017

Re: KRISGO post# 758183

Tuesday, 04/01/2025 1:23:44 PM

Tuesday, April 01, 2025 1:23:44 PM

Post# of 818250

The Company has also been in negotiations since early Q4 2024 for potential acquisition of another company with a dendritic cell related technology. The Company hopes to complete these negotiations during Q2 or Q3 2025.

- Unless we receive MHRA approval and support from a big pharma, it’s risky to move forward with these kinds of deals due to our current stock trading situation. As Femike mentioned, they could do a reverse split and secure enough funding to move forward, but this will likely reduce our shareholders' value, possibly by as much as 10% of what we’re worth now.



Acquiring a company and yet you can barely keep your own lights on.

This is to proved that the CEO is an idiot whose on a buying spree despite on what she put on her 10k on-going concerns. What a bunch of clowns. She doesn't care for the ones feeding her.

SHAME ON YOU LINDA POWERS! STEP DOWN!!!!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News